RecruitingNCT05032053
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
Sponsor
Xijing Hospital
Enrollment
3,000 participants
Start Date
Mar 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
To observe the effect of different antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds. And further combined with proteomic methods to explore serological markers that can be used to accurately predict the prognosis of such patients.
Eligibility
Min Age: 40 Years
Inclusion Criteria4
- Patients diagnosed clinically as ischemic stroke;
- Age ≥ 40 years;
- Onset time ≤ 3 months;
- Informed consent was signed.
Exclusion Criteria6
- Patients with symptomatic intracranial hemorrhage;
- bleeding lesion > 10 mm was found on SWI;
- Vascular malformations, tumors, abscesses or other major non ischemic brain diseases were present;
- There are contraindications for antithrombotic drugs use;
- Serious systemic diseases;
- Refusal to sign informed consent or poor compliance.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAntithrombotic drugs
The purpose of our study is to observe the effect of various antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds.
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05032053
Related Trials
A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With Acute Ischemic Stroke
NCT0736710015 locations
Michigan Initial Experience Using Tigertriever for Thrombectomy
NCT073635251 location
Continuous Dual Aspiration Technique With Zoom System for Stroke
NCT074919529 locations
Modulation of Cerebral Ischemia by Albumin
NCT074156551 location
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke
NCT0750964513 locations